3/24
08:03 am
nrix
Nurix Therapeutics (NRIX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.
Low
Report
Nurix Therapeutics (NRIX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.
3/23
04:05 pm
nrix
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
Low
Report
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
2/28
02:23 am
nrix
Nurix Therapeutics (NRIX) Valuation Check After Recent Share Price Volatility And Rich Price To Sales Multiple [Yahoo! Finance]
Low
Report
Nurix Therapeutics (NRIX) Valuation Check After Recent Share Price Volatility And Rich Price To Sales Multiple [Yahoo! Finance]
2/4
10:36 pm
nrix
Nurix Therapeutics (NRIX) Is Down 7.4% After Wider 2025 Losses And New ESOP Share Shelf - What's Changed [Yahoo! Finance]
Medium
Report
Nurix Therapeutics (NRIX) Is Down 7.4% After Wider 2025 Losses And New ESOP Share Shelf - What's Changed [Yahoo! Finance]
2/2
10:09 pm
nrix
Nurix Therapeutics, Inc. (NRIX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Nurix Therapeutics, Inc. (NRIX): A Bull Case Theory [Yahoo! Finance]
2/2
09:40 am
nrix
Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts [Yahoo! Finance]
Low
Report
Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts [Yahoo! Finance]
1/29
11:48 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $30.00. They now have an "outperform" rating on the stock.
Low
Report
Nurix Therapeutics (NASDAQ:NRIX) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $30.00. They now have an "outperform" rating on the stock.
1/29
10:04 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) was given a new $35.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Nurix Therapeutics (NASDAQ:NRIX) was given a new $35.00 price target on by analysts at Stifel Nicolaus.
1/29
08:43 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Nurix Therapeutics (NASDAQ:NRIX) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
1/29
08:27 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $30.00 price target on the stock.
Low
Report
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $30.00 price target on the stock.
1/29
08:03 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Medium
Report
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
1/29
08:03 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Medium
Report
Nurix Therapeutics (NASDAQ:NRIX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
1/29
07:03 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/28
04:01 pm
nrix
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
Low
Report
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
1/25
12:33 pm
nrix
Assessing Nurix Therapeutics (NRIX) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Low
Report
Assessing Nurix Therapeutics (NRIX) Valuation After Recent Share Price Volatility [Yahoo! Finance]
1/16
07:16 am
nrix
Nurix Therapeutics: Why This Company Could Double In Value? [Seeking Alpha]
Medium
Report
Nurix Therapeutics: Why This Company Could Double In Value? [Seeking Alpha]
1/12
07:20 am
nrix
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases [Yahoo! Finance]
Medium
Report
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases [Yahoo! Finance]
1/12
07:00 am
nrix
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
Medium
Report
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
1/8
07:09 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) was given a new $36.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Medium
Report
Nurix Therapeutics (NASDAQ:NRIX) was given a new $36.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
1/5
07:00 am
nrix
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference